From: Validation of the japanese version of the sarcoidosis health questionnaire: A cross-sectional study
Mean ± SD or n (%) | Range | |
---|---|---|
Age, years | 56.8 ± 15.5 | 24 - 85 |
Female | 74 (60.6%) | |
Duration of sarcoidosis (months) | 108.9 ± 86.2 | 2 - 395 |
Number of organ systems involved | 1.8 ± 0.8 | 1 - 5 |
Radiographic stage | 37/32/33/15/5 | |
(0/I/II/III/IV) | (30.3%/26.2%/27.0%/12.3%/4.1%) | |
Blood laboratory tests | ||
ACE, IU/L | 17.2 ± 6.5 | 3.8 - 41.7 |
sIL-2R, IU/mL | 639.9 ± 507.5 | 128 - 3772 |
Pulmonary function tests | ||
FVC, %predicted | 105.8 ± 18.5 | 44.3 - 146.4 |
FEV1, %predicted | 105.8 ± 21.0 | 35.0 - 158.7 |
DLCO, %predicted | 85.1 ± 17.2 | 33.7 - 133.3 |
Echocardiogram | ||
LVEF, % | 68.1 ± 11.4 | 31.8 - 79.5 |
PASP, mmHg | 29.4 ± 5.9 | 19.0 - 57.4 |
SHQ | ||
4.7 ± 1.0 | 2.1 - 6.7 | |
5.4 ± 1.0 | 2.7 - 6.8 | |
4.8 ± 1.0 | 2.2 - 6.9 | |
4.9 ± 0.9 | 2.4 - 6.7 | |
SF-36 | ||
Physical functioning [0-100] | 79.2 ± 20.9 | 0 - 100 |
Role-physical [0-100] | 77.1 ± 27.0 | 0 - 100 |
Bodily pain [0-100] | 71.9 ± 26.7 | 0 - 100 |
General health perceptions [0-100] | 50.0 ± 19.7 | 0 - 97 |
Vitality [0-100] | 52.2 ± 23.1 | 0 - 100 |
Social functioning [0-100] | 78.6 ± 24.1 | 0 - 100 |
Role-emotional [0-100] | 77.7 ± 25.7 | 0 - 100 |
Mental health [0-100] | 66.6 ± 20.5 | 5 - 100 |
SGRQ | ||
Symptoms [0-100] | 39.8 ± 20.6 | 0 - 86.5 |
Activity [0-100] | 29.7 ± 24.9 | 0 - 92.5 |
Impact [0-100] | 14.6 ± 14.6 | 0 - 57.3 |
Total [0-100] | 23.4 ± 16.3 | 0 - 71.8 |
1.8 ± 0.8 | 1 - 5 | |
CES-D [0-60] | 12.8 ± 9.3 | 0 - 45 |